Host antimicrobial peptide induction

Host antimicrobial peptide induction" refers to the **biological process** by which an organism's cells increase the production of endogenous antimicrobial peptides (AMPs), also known as host defense peptides. AMPs are small cationic molecules that play a crucial role in innate immunity across all classes of life[1][2][4]. They exhibit broad-spectrum activity against bacteria, fungi, viruses, and even some cancer cells by disrupting microbial membranes and interfering with intracellular processes such as DNA/RNA/protein synthesis[1][2][3]. Induction of these peptides can occur in response to infection or inflammation and is regulated by various signaling pathways and transcription factors. While AMPs themselves are considered promising therapeutic agents—especially for combating antibiotic-resistant pathogens—the term "host antimicrobial peptide induction" does not refer to a single molecular target but rather describes an immune activation pathway or cellular response[1][2][4]. Therefore, it is **not considered a canonical drug target** like receptors or enzymes. > In summary: "Host antimicrobial peptide induction" is not itself a molecule/receptor but describes the upregulation process of endogenous AMPs—a critical component of innate immunity with significant therapeutic interest but not suitable for classification as an individual druggable target[1][2][4].

Other names

Host defense peptide inductionAMP inductionHDP induction